Darwin Global Management, Ltd. Quant / Systematic

Location: St. Helier, Jersey

CIK: 0001839209 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $751M (100.0% shares, 0.0% debt)

Holdings (12)

PCVX VAXCYTE INC 25.0%
Value $188M Shares 2,750,804 Est. Cost $65.60 Unrealized +5.6%
NUVL NUVALENT INC 14.4%
Value $108M Shares 1,436,964 Est. Cost $78.87 Unrealized +0.9%
KROS KEROS THERAPEUTICS INC 12.7%
Value $95.06M Shares 1,435,950 Est. Cost $38.66 Unrealized +53.4%
BHVN BIOHAVEN LTD 10.8%
Value $80.78M Shares 1,476,974 Est. Cost $49.52 Unrealized 0.0%
— ALPINE IMMUNE SCIENCES INC 10.5%
Value $78.57M Shares 1,982,016 Est. Cost $39.64 Unrealized —
BEAM BEAM THERAPEUTICS INC 9.3%
Value $70.03M Shares 2,119,598 Est. Cost $31.16 Unrealized 0.0%
APGE APOGEE THERAPEUTICS INC 7.4%
Value $55.3M Shares 832,198 Est. Cost $43.66 Unrealized 0.0%
XNCR XENCOR INC 3.3%
Value $24.56M Shares 1,109,650 Est. Cost $21.61 Unrealized 0.0%
SYRE SPYRE THERAPEUTICS INC 2.4%
Value $17.95M Shares 473,200 Est. Cost $28.97 Unrealized 0.0%
— ELEVATION ONCOLOGY INC 1.6%
Value $11.97M Shares 2,332,928 Est. Cost $5.13 Unrealized —
— TOURMALINE BIO INC 1.4%
Value $10.65M Shares 465,000 Est. Cost $22.90 Unrealized —
MRK MERCK & CO INC 1.4%
Value $10.5M Shares 79,600 Est. Cost $115.77 Unrealized 0.0%